Novocure Enrolls First Patient in Phase 3 Pivotal Brain Metastases Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. SPY
3. EL
4. ADI
5. ROST
6. BILL
7. WMT
8. MRK
9. MRNA
10. MRVL

Go back to Novocure Enrolls First Patient in Phase 3 Pivotal Brain Metastases Trial
(NASDAQ: NVCR) Delayed: 17.77 -0.43 (2.36%)
Previous Close $18.20    52 Week High $28.95 
Open $18.12    52 Week Low $5.95 
Day High $18.61    P/E N/A 
Day Low $17.48    EPS $0.00 
Volume 954,930